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TPM Z-score Figure 10) . Low levels of SCGB1A1 transcripts were detected in cluster C-10 (SCGB1A1 low ) and CFTR was expressed by cluster C-13, which suggests that these cells may be ionocytes 21 ( Supplementary Figure 11) .
Marker gene expression was not detected in clusters C-6, C-9, and C-12 ( Figure 2c ).
Enrichment of current smoker cells was observed in goblet cell cluster C-3, as well as C-9 and C-12, whereas enrichment of never smoker cells was observed in club cell cluster C-1, SCGB1A1 low cluster C-10 and basal clusters C-2 and C-4 ( Figure 2d ).
Furthermore, a subset of gene sets expressed by specific clusters of ciliated-, club-, goblet-, and basal cells, as well as those without a cell type designation, were differentially expressed between never-and current smokers in transcriptomic data generated from bulk bronchial tissue 18 
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Ciliated cell subpopulations and smoking-induced detoxification.
We characterized transcriptomic similarities and differences amongst FOXJ1 + clusters C-5 and C-11 in order to define ciliated cell subpopulations detected in never and current smokers. Our data revealed that both clusters of ciliated cells expressed gene set GS-2, but could be differentiated based on expression of gene set GS-3 by cluster C-5 and gene set GS-7 by cluster C-11 ( Figure 3a) . GS-2 contains FOXJ1, in addition to genes involved with ciliary assembly, maintenance, and function, such as motor protein genes (e.g. DYNLL1, DNAH9) and intraflagellar transport genes (e.g. IFT57, Table 3) . GS-2 also includes antioxidant genes (e.g. PRDX5, GPX4, GSTA2), known transcriptional regulators of ciliogenesis (e.g. RFX2 [22] [23] , RFX3 [24] [25] , and surface proteins not previously attributed to ciliated cells (e.g. CDHR3, CD59). GS-3 also contains genes with known roles in airway ciliary biology, such as IFT88 [26] [27] [28] (required for ciliary formation) and DNAH5 [29] [30] [31] (required for ciliary motility). By contrast, gene set GS-7 is enriched with cell cycleassociated genes (Extended Supplementary Table 3) , such as CDK1 and CCNB1
IFT172) (Figure 3a, Extended Supplementary
(G1/S transition) and TOP2A (S-phase DNA replication), as well as the transcription factor, HES6. Therefore, clusters C-5 and C-11 likely represent functionally distinct subpopulations of FOXJ1 + ciliated cells.
We found that ciliated cells from current smokers expressed a distinct transcriptional signature. Specifically, the current smoker subset of cluster C-5 FOXJ1 + cells expressed gene set GS-8, which was enriched with genes encoding enzymes implicated in aldehyde and ketone metabolism, such as ALDH3A1, AKR1C1, and AKR1B10 ( Figure   3b ). This finding suggested that the gene expression response to toxic aldehydes and ketones present in tobacco smoke [8] [9] might be restricted to ciliated epithelial cells. To confirm that this set of enzymes localized to ciliated cells, we immunostained bronchial tissue procured from an independent cohort of never and current smokers (UMCG Cohort, Supplementary Table 2) for the aldo-keto reductase AKR1B10, as well as ciliaspecific acetylated alpha tubulin (Ac-α-Tub) and the luminal cytokeratin, KRT8, which is expressed by all non-basal cells (Figure 3c) . We found that AKR1B10 was robustly Figure 13a) , but AKR1B10 + KRT8 -cells were not observed. We also confirmed that AKR1B10 was not expressed by current smoker MUC5AC + goblet cells (Supplementary Figure 13b) . Overall, these results demonstrate that ciliated cells express a specific set of detoxification genes in response to smoke exposure. + Ac--Tub CCNO  TOP2A  CDC20B  CDK1  TUBA1B  HES6   MUC15  IFT88  FABP6  CCDC33  CDHR4  PROM1  DNAH5  IGFBP7   CKB   CTGF  GSTA3  MUC12  AGR3  RFX3  GSTA2  DYNLRB1  GPX4   IFT140  MUCL1  CD59  RFX2  IFT172  DNAH10   FOXJ1  PRDX5  CCDC176   DNAH9  IFT57  CETN2  DYNLL1   TPPP3  CDHR3  TUBA1A   DNAH6  COPRS  DNAH11   IFT27   TUBB4B   DNAI1 The MUC5AC + goblet cell cluster C-3 was significantly enriched with current smoker cells (Figure 2d) , which is consistent with prior studies showing that smoking is associated with increased bronchial goblet cell abundance [12] [13] [14] . Cluster C-3 expressed gene set GS-1, which contains the goblet cell marker gene, MUC5AC, as well as several genes with known roles in goblet cell biology, such as SPDEF 34 , AGR2 35 , and TFF3 36 (Figure 4a ). Genes associated with the unfolded protein response (UPR) are present in GS-1 (e.g. KDLER3, DNAJC10) (Extended Supplementary Table 3) . We also identified several unique goblet cell surface markers (e.g. CLDN10, TSPAN8, TSPAN13), as well as a transcription factor (NKX3-1) whose role in the goblet cell transcriptional program is unknown (Figure 4a) . Therefore, this data indicates that smoking is associated with increased numbers of MUC5AC + goblet cells.
To confirm smoking-associated shifts in club and goblet cell numbers, bronchial tissue procured from an independent cohort of never and current smokers (UMCG Cohort, Figure 14) . Overall, these findings indicate that smoking is associated with a loss of club cells, increased numbers of goblet cells, and substantial GCH airway remodeling. SPDEF  SEC61A1  CLDN10  MAGED1  ANG  TSPAN13  DNAJC10  KDELR3  DHX35  TFF1  TSPAN8  AGR2  TFF3 We sought to establish the identity of cluster C-9, which was strongly enriched with current smoker cells and did not express established cell type marker genes (e.g.
Supplementary
KRT5, FOXJ1, SCGB1A1, MUC5AC) (Figure 2c ). C-9 cells expressed high levels of gene set GS-12, which contains the luminal cytokeratin KRT8 (Figure 5a ). Additional cytokeratin genes were also present in GS-12, such as KRT13 and KRT19, as well as anti-oxidant genes, like TXN and GPX1 (Figure 5a ). Cluster C-9 also expressed gene set GS-16, which was detected at low levels in MUC5AC + cells (C-3) and contained the xenobiotic metabolism gene, CYP1B1 (Figure 5a) . Furthermore, high expression of gene set GS-15 was detected in both C-9 cells and MUC5AC + cells (C-3) (Figure 5a-c) ,
suggesting that this cluster may have a functional relationship with goblet cells. GS-15
contains several genes previously reported to be persistently up-regulated post-smoking cessation (e.g. CEACAM5, CEACAM6, UPK1B) 18 , one of which has been explicitly linked to lung squamous cell carcinoma (SCC) and premalignancy (CEACAM5) 37 .
To validate the presence of cluster C-9 cells in the airways of current smokers, bronchial tissue procured from a second independent cohort of never-and current smokers (UCL Cohort, Supplementary CEACAM5 expression in goblet cells was phenotypically punctate and co-localized with MUC5AC in both never and current smokers (Figure 5d) . In PG cells, however, CEACAM5 distinctively localized to the cell surface and nucleus (Figure 5d) Table 3) was immunostained for CEACAM5, KRT8, and MUC5AC. Representative images of never smoker tissue (left), morphologically normal current smoker tissue (middle), and current smoker goblet cell hyperplasia (GCH) (right) were displayed. Changes in tissue length (μm)-normalized numbers of (e) CEACAM5+ KRT8+ MUC5AC-cells in current smoker morphologically normal and GCH tissue were assessed relative to never smokers by WRS test.
DISCUSSION
Previous transcriptomic studies have shown that smoking is associated with a robust bronchial gene expression signature [17] [18] . Interrogation of bronchial tissue at single-cell resolution revealed that elements of this signature were derived from different cell subpopulations. Overall, we discovered smoking-associated phenotypes that included a metabolic response that localized to ciliated cells, a cell type shift that involved club cell loss and goblet cell expansion, and a previously uncharacterized subpopulation of perigoblet (PG) epithelial cells present within regions of goblet cell hyperplasia.
We identified a gene set (GS-8) specifically expressed by smoker ciliated cells (C-5)
that contains genes encoding families of enzymes, such as aldehyde dehydrogenases (e.g. ALDH3A1, ALDH1A3) and aldo-keto reductases (e.g. AKR1B10, AKR1C1), capable of breaking down tobacco smoke-derived chemical compounds, like toxic aldehydes (e.g. formaldehyde, acrolein) and ketones (e.g. acetone, methyl vinyl ketone) [8] [9] . This finding suggests that ciliated cells exhibit a cell type-specific coping mechanism that may convey resistance to certain forms of smoking-induced toxicity.
Links between this mechanism and previously reported smoking phenotypes, such as reduced ciliary length 15 , however, are unclear. This finding might also highlight a protective function with tissue-wide significance, in which the bronchial epithelium's capacity for detoxification may be compromised if ciliated cells are lost due to injury or disease.
Several studies have reported that smoking is associated with increased mucous production and goblet cell hyperplasia in the bronchus [12] [13] [14] [38] [39] [40] . Loss of club cells (SCGB1A1 + ) has been reported in smoker bronchioles [11] [12] , but this is the first instance in which a similar observation has been made in the mainstem bronchus. We confirmed that goblet cell hyperplasia (GCH) is a regional phenomenon interspersed amongst morphologically normal (MN) tissue areas. The determinants of GCH prevalence are unclear, but it has been shown that cytokines (e.g. IL-13 and IL-4) [41] [42] [43] and viral infection (e.g. Rhino virus and Poly(I:C)) [44] [45] can increase MUC5AC expression and goblet cell abundance. The specific catalyst for GCH in response to smoke exposure is unknown, but reports of its co-occurrence with airway inflammation suggest that immunological interplay may be a factor 14 . Furthermore, there is evidence that both basal and club cells are capable of goblet cell differentiation 32, 46 . However, the origins of newly formed goblet cells in the airways of smokers have not been explicitly described. Functional implications for goblet cell expansion and club cell loss are unclear, but a similar phenotype has been described in the airways of asthmatics, in which diminished mucosal fluidity, the formation of mucosal plugs, and impaired mucociliary clearance was observed [47] [48] . Murine models have also shown that MUC5B loss is associated with impaired mucociliary clearance, airflow obstruction, and respiratory infection 49 .
Smoking-induced GCH was associated with the presence of a previously 
METHODS
Bronchial tissue collection for single-cell RNA sequencing
At Boston University Medical Center (BUMC), healthy, volunteer never smokers (n=6) and current smokers (n=6) underwent a bronchoscopy to obtain brushings from the right main-stem bronchus as described previously described [17] [18] . were frozen on dry ice, and stored at -80 °C until preparation for sequencing.
Single-cell RNA sequencing
Massively parallel single-cell RNA-sequencing of human bronchial airway cells was performed using a modified version of the CEL-Seq RNA library preparation protocol 20 .
For each of the 12 recruited donors, one frozen 96-well PCR plate containing sorted cells was thawed on ice and RNA was directly reverse transcribed (ThermoFisher; AM1751) from whole cell lysate using primers composed of an anchored poly(dT), the 5'
Illumina adaptor sequence, a 6-nucleotide well-specific barcode, a 5-nucleotide unique molecular identifier (UMI), and a T7 RNA polymerase promoter. All primer sequences were listed in Extended Supplementary Table 1 . Samples were additionally supplemented with ERCC RNA Spike-In mix (ThermoFisher; 4456740) (1:1,000,000 dilution) for quality control. cDNA generated from each of the 96 cells per plate was pooled, subjected to second strand synthesis (ThermoFisher; AM1751) and amplified by nucleotides, and append UMI information from read 1 (R1) to the header of read 2 (R2);
2) perform genomic alignment of R2 with Bowtie2 (v2.2.2) using a concatenated hg19/ERCC reference assembly; and 3) convert aligned reads to gene-level counts using a modified version of the HTSeq (v0.5.4p1) python library that identifies reads aligning to the same location with identical UMIs and reduces them to a single count.
One UMI-corrected count was then referred to as a "transcript". The pipeline was configured with the following settings: alignment quality (min_bc_quality) = 10, barcode length (bc_length) = 6, UMI length (umi_length) = 5, cut_length = 35.
Data quality control
The quality of each cell was assessed by examining the total number of reads, total reads aligned to hg19, total reads aligning to genes (pre-UMI correction), total transcript counts, and total genes with at least one detected transcript. Cells were excluded from downstream analyses if the total number of transcripts were not two-fold greater than the total background-level transcripts detected in the empty well negative control on each plate (Supplementary Figure 3) . Cells were also excluded from downstream analyses if there was a weak Pearson correlation (r < 0.7) between detected ERCC RNA Spike-in transcript counts (Log 10 ) and ERCC input concentration (Log 10 ) (amol/mL) (Supplementary Figure 3) . All non-protein-coding genes and genes with less than 2 transcript counts in 5 cells were removed from the dataset. The remaining 7680 genes measured across 796 cells were used for subsequent analyses.
Latent Dirichlet allocation (LDA) implementation and model optimization
Latent Dirichlet Allocation (LDA) from the topicmodels R package (v0.2-6) was used to generate probabilistic representations of cell clusters and gene sets present in the dataset, referred to as Cell-States and Gene-States. The input for the Cell-State model required a counts data matrix where cells were columns and genes were rows, whereas for the Gene-State model, the same matrix was transposed (ie. genes were columns and cells were rows). Models were fit using the Variational Expectation-Maximization (VEM) algorithm with the following parameters: nstart = 5, seed = 12345, estimate.alpha = TRUE, estimate.beta = TRUE. The given parameter "k" determined the number of
Cell-States and Gene-States to be estimated by the model. The optimal value of k was determined by 5-fold cross validation and evaluation of model perplexity. For the GeneState model, cells were randomly partitioned into "training" (80%) and "test" (20%) sets, whereas for the Cell-State model, genes were randomly partitioned into "training" (80%)
and "test" (20%) sets. Models were then fit to the training set and perplexity was estimated to evaluate model fit for the held-out test set. Fifty iterations of this process were performed for k = 2-50, mean perplexity was calculated at each k, and the minimum mean perplexity was selected as the optimal value of k (ie. k.opt), which was k 
Gene set (GS) and cell cluster (C) assignments
Negative binomial generalized linear models were built using the MASS R package 
Data visualization by heatmap and t-SNE
Prior to heatmap visualization, transcript counts were transformed to z-normalized transcripts per million (TPM). Genes (top-to-bottom) and cells (left-to-right) were ordered according to the strength of statistical association (FDR q) with respective assigned Gene-States and Cell-States. The tsne R package v0.1-3 was used for dimensionality reduction by t-distributed stochastic neighbor embedding (t-SNE).
Modified parameters include: k = 2, seed = 1234. Input for t-SNE was z-normalized transcripts per million (TPM) values across genes with at least 3 transcript counts in 3 cells (n = 4,914 genes). Gene expression overlay onto t-SNE visualization was also performed using z-normalized TPM values.
Functional annotation
The enrichR R package (v0.0.0.9000) was used as an interface for the web-based functional annotation tool, Enrichr, to identify Gene Ontology terms from the GO Biological Process 2015 library significantly associated with each gene set [51] [52] .
Functional annotation results were listed in Extended Supplementary Table 3 .
Microarray data processing
Raw CEL files obtained from the Gene Expression Omnibus (GEO) for Series GSE7895
were normalized to produce gene-level expression values using the implementation of Figure 4b) .
Gene set expression analysis in microarray data
Using published microarray data generated from bulk bronchial brushings procured from never and current smokers (GEO Series GSE7895), RMA-transformed values for each gene were z-normalized. MetaGene values were then generated by computing the mean z-score across all genes in each gene set (GS-1 to 19) for each sample. For each MetaGene, differential expression between never and current smoker samples was assessed using the Wilcoxon Rank Sum (WRS) test. For each smoking-associated MetaGene (p < 0.05), if the mean current smoker value was greater than-or less thanthe mean never smoker value, the gene set was considered to be up-or downregulated in current smokers, respectively. 
Cell type assessment for cell clusters
Gene set expression analysis in cell clusters
Transcript counts were transformed to z-normalized transcripts per million (TPM).
MetaGene values were then generated by computing the mean z-score across all genes in each gene set (GS-1 to 19) for each cell. Cluster-specific MetaGene expression was designated: high (pink) if mean expression exceeded one standard deviation above the mean value across all cells; medium (white) if mean expression exceeded one half of a standard deviation above the mean value across all cells; low (light grey) if mean expression exceeded the mean value across all cells. Clusterspecific mean expression below the mean value across all cells indicated that a given cluster did not express a given gene set (dark grey).
Bronchial tissue collection for immunostaining
Bronchial tissue was collected from patients undergoing lung resection. All specimens were procured at least 5 cm from bronchial sites affected by disease diagnoses and analyses indicated that tissue was histologically normal. The UMCG Cohort (Supplementary Table 2 Table 3 ) (e.g. CEACAM5 / KRT8 / MUC5AC, Figure 5d ; KRT8 / MUC5AC / Ac-α-Tub, Supplementary Figure 15 ) was performed using a Leica TCS Tandem confocal microscope at 63x objective magnification.
Imaging analysis
All imaging data was analyzed using ImageJ Fiji software. For each image, cells were counted relative to the measured length of the epithelium in microns (cells/µm). Mean cell counts per micron (cells/µm) was then calculated for never smokers (treated as the control) and individual values for each image from never and current smokers were calculated relative to the never smoker mean (ie. relative cells/µm). We analyzed three images for each donor and assessed smoking-associated changes using the Wilcoxon rank-sum test. For panels in which MUC5AC was stained, current smoker tissue was assigned phenotypic status of either "morphologically normal" (MN) or "goblet cell hyperplasia" (GCH), based on qualitative assessment of goblet cell density and stratification. For each current smoker, three images of each status were analyzed.
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